Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie acquires STING pathway-focused Mavupharma

pharmaceutical-technologyJuly 17, 2019

Tag: AbbVie , Acquires , Mavupharma

PharmaSources Customer Service